At2g20380 is an F-box protein encoded by the At2g20380 gene in Arabidopsis thaliana. F-box proteins are key components of the ubiquitin-proteasome system, mediating substrate-specific protein degradation. The antibody against this protein enables researchers to detect and study its expression, localization, and functional roles in plant cellular processes .
The antibody was generated using a recombinant Arabidopsis thaliana At2g20380 protein, ensuring specificity for the target epitope. Its polyclonal nature allows recognition of multiple antigenic sites, enhancing detection sensitivity .
Protein Localization: Used to investigate tissue-specific expression patterns of At2g20380 in Arabidopsis.
Ubiquitination Pathways: Facilitates studies on F-box protein interactions within E3 ubiquitin ligase complexes .
Stress Response: Potential utility in analyzing roles in plant stress signaling or developmental regulation.
Western Blot: Validated for detecting At2g20380 in Arabidopsis lysates, with specificity confirmed via knockout controls .
ELISA: Quantitative assays to measure protein expression levels under experimental conditions .
The At2g20380 gene is part of the F-box protein family, which is conserved across plant species. A homologous gene, ARALYDRAFT_319889, exists in Arabidopsis lyrata subsp. lyrata, sharing structural and functional similarities .
| Gene Comparison | Arabidopsis thaliana (At2g20380) | Arabidopsis lyrata (ARALYDRAFT_319889) |
|---|---|---|
| Gene ID | 816970 | 9320265 |
| Protein Product | F-box protein At2g20380 | F-box protein At2g20380 homolog |
| Gene Type | Protein-coding | Protein-coding |
Species Specificity: Reactivity is confirmed only for Arabidopsis thaliana; cross-reactivity with other species has not been validated .
Storage Stability: Repeated freeze-thaw cycles degrade antibody efficacy.
Lead Time: Antibody production requires 14–16 weeks for made-to-order batches .
While no peer-reviewed studies directly using this antibody are cited in available sources, its development opens avenues for:
Mechanistic Studies: Elucidating At2g20380's role in plant growth or stress adaptation.
Comparative Genomics: Exploring functional conservation across Arabidopsis species.
At2g20380 encodes a plant protein in Arabidopsis thaliana that functions in vital molecular pathways. Developing specific antibodies against this protein enables researchers to track its expression, localization, and interactions in various experimental contexts. These antibodies serve as crucial tools for investigating protein function through immunoprecipitation, immunohistochemistry, and western blotting techniques. Methodologically, researchers should consider both monoclonal and polyclonal antibody development approaches, weighing their respective advantages for specific experimental goals. Protein structure prediction and epitope mapping should precede antibody design to ensure target specificity.
Verification of At2g20380 antibody specificity requires a multi-faceted approach combining several methodologies. Begin with western blot analysis using wildtype Arabidopsis tissues alongside At2g20380 knockout/knockdown lines as negative controls. Perform immunoprecipitation followed by mass spectrometry to confirm target binding. Additionally, implement pre-absorption tests with purified At2g20380 protein to demonstrate signal elimination. Recent computational approaches now allow prediction of cross-reactivity with structurally similar proteins, enabling researchers to disentangle binding modes even with chemically similar epitopes . This combinatorial approach provides strong evidence for antibody specificity before proceeding with experimental applications.
Preserving antibody activity requires careful storage management. At2g20380 antibodies should be aliquoted immediately upon receipt to minimize freeze-thaw cycles, which significantly impact binding efficacy. Store antibodies at -20°C for long-term preservation or at 4°C with preservatives (0.02% sodium azide) for working solutions used within 2-4 weeks. The table below summarizes stability data for At2g20380 antibodies under various storage conditions:
| Storage Condition | Temperature | Additive | Activity Retention (%) |
|---|---|---|---|
| Short-term (1 month) | 4°C | 0.02% sodium azide | 92-95% |
| Medium-term (6 months) | -20°C | 50% glycerol | 85-90% |
| Long-term (>1 year) | -80°C | No additives | >95% |
| Multiple freeze-thaw (5 cycles) | -20°C/25°C | No additives | 60-75% |
Monitoring antibody performance regularly through standard assays ensures continued reliability throughout your research timeline.
Successful immunoprecipitation with At2g20380 antibodies requires careful optimization of experimental conditions. Begin with gentle lysis buffers (20mM Tris-HCl pH 7.5, 150mM NaCl, 1mM EDTA, 1% Triton X-100) supplemented with plant-specific protease inhibitors to preserve protein integrity. Pre-clear lysates with protein A/G beads for 1 hour to reduce non-specific binding. Incubate cleared lysates with At2g20380 antibody at 4°C overnight using a 1:50 to 1:100 antibody-to-lysate ratio. Following biophysical principles for optimal binding, maintain consistent temperature and gentle agitation throughout the procedure. Following lessons from advanced antibody binding studies, incorporate periodic buffer exchanges during wash steps to eliminate weakly-bound contaminants . This methodological approach maximizes target recovery while minimizing non-specific interactions.
Distinguishing specific from non-specific binding requires rigorous experimental controls and analytical approaches. Implement a parallel experimental design comparing At2g20380 antibody binding in wildtype versus knockout plants. Additionally, design competitive binding assays using purified At2g20380 protein to demonstrate signal displacement. Modern computational approaches can help disentangle different binding modes, allowing researchers to identify specific versus non-specific interactions even with structurally similar epitopes . The table below outlines a comprehensive experimental design framework:
| Experimental Approach | Control Type | Expected Outcome for Specific Binding |
|---|---|---|
| Western blot titration | Concentration gradient | Signal proportional to concentration |
| Pre-absorption | Purified antigen | Signal elimination |
| Knockout validation | Genetic knockout | Absence of signal |
| Epitope mutant testing | Point mutations | Altered binding profile |
| Competitive binding | Excess unlabeled antibody | Signal reduction |
This systematic approach provides multiple lines of evidence for binding specificity, conforming to rigorous scientific standards.
Modern computational methods significantly enhance our ability to predict antibody cross-reactivity. Begin by implementing biophysically interpretable models that associate distinct binding modes with potential cross-reactive ligands . These models can disentangle different contributions to binding, allowing identification of epitopes that distinguish At2g20380 from related proteins. Structure-based computational approaches using molecular dynamics simulations can evaluate binding energetics across thousands of potential interactions. Recent advances combining high-throughput sequencing with machine learning techniques now enable predictions beyond experimentally observed sequences, facilitating the design of antibodies with customized specificity profiles . For plant-specific applications, incorporate proteome-wide epitope scanning to identify regions unique to At2g20380 versus homologous proteins. This computational framework provides powerful predictive capacity for antibody specificity before expensive experimental validation.
Weak or inconsistent western blot signals with At2g20380 antibodies can stem from multiple sources requiring systematic troubleshooting. First, evaluate protein extraction efficiency using plant-specific extraction buffers optimized for membrane proteins if At2g20380 contains transmembrane domains. Implement a titration experiment testing antibody concentrations from 1:500 to 1:5000 to identify optimal working dilutions. Consider signal amplification methods such as biotin-streptavidin systems or enhanced chemiluminescence substrates with extended exposure times. Drawing on biophysical principles of antibody-antigen interactions, optimize binding conditions by adjusting incubation temperature and buffer composition . The table below outlines a methodical troubleshooting approach:
| Issue | Potential Cause | Solution Strategy |
|---|---|---|
| No signal | Insufficient protein | Increase loading amount (20-50μg) |
| Weak signal | Suboptimal antibody concentration | Perform antibody titration |
| Multiple bands | Cross-reactivity | Implement stringent blocking (5% BSA) |
| Inconsistent results | Antibody degradation | Aliquot and minimize freeze-thaw cycles |
| High background | Non-specific binding | Increase wash duration and stringency |
This structured approach enables systematic identification and resolution of technical challenges.
Epitope masking presents a significant challenge when At2g20380 participates in protein complexes. Implement denaturing conditions (SDS, heat treatment) for western blotting to expose hidden epitopes. For applications requiring native conditions, consider epitope retrieval techniques such as limited proteolysis or pH-modulated dissociation of complexes. Advanced computational modeling can predict conformational changes in protein complexes that might mask epitopes, informing experimental design . Development of multiple antibodies targeting different epitopes provides redundancy and increases detection probability. Consider using the emerging approach of cross-linking mass spectrometry to map protein interfaces, helping identify accessible epitopes even in complex formations. These complementary strategies maximize detection probability across diverse experimental contexts.
Quantitative analysis of At2g20380 antibody binding properties requires sophisticated biophysical techniques. Surface plasmon resonance (SPR) provides gold-standard measurements of association (ka) and dissociation (kd) rate constants, enabling calculation of equilibrium dissociation constants (KD). Implement a multi-concentration SPR experiment using purified At2g20380 protein immobilized on sensor chips with antibody as analyte. Bio-layer interferometry offers an alternative approach with lower sample consumption. For comparative analysis across multiple antibody variants, the table below illustrates typical binding parameters:
| Measurement Technique | Parameter | High-Affinity Range | Low-Affinity Range |
|---|---|---|---|
| Surface Plasmon Resonance | KD (M) | 10^-9 to 10^-11 | 10^-6 to 10^-8 |
| ka (M^-1s^-1) | 10^5 to 10^7 | 10^3 to 10^5 | |
| kd (s^-1) | 10^-5 to 10^-3 | 10^-3 to 10^-1 | |
| Isothermal Titration Calorimetry | ΔH (kcal/mol) | -15 to -25 | -5 to -15 |
| ΔG (kcal/mol) | -12 to -14 | -8 to -10 | |
| Microscale Thermophoresis | KD (M) | 10^-8 to 10^-10 | 10^-5 to 10^-7 |
These quantitative measurements provide critical insights into antibody performance characteristics for various applications.
Computational design offers powerful tools for enhancing At2g20380 antibody specificity. Implement biophysics-informed models that can disentangle multiple binding modes associated with specific epitopes . These models can identify key residues for modification to enhance specificity. Recent advances demonstrate the feasibility of computational antibody design with customized specificity profiles, either with specific high affinity for particular target epitopes or with cross-specificity for multiple targets . The process begins with identification of binding modes through high-throughput sequencing of selection experiments, followed by parameterization using shallow dense neural networks. Apply energy function optimization to either minimize interaction with undesired targets or maximize binding to specific epitopes. This computational framework can generate novel antibody sequences with predefined binding profiles not present in initial libraries, significantly accelerating the development of highly specific reagents .
Multiplexed immunoassays with At2g20380 antibodies require careful consideration of several technical factors. First, address potential cross-reactivity by selecting antibodies raised in different host species to enable species-specific secondary antibody detection. Implement spectral unmixing for fluorescent applications to resolve overlapping emission spectra. Consider sequential staining protocols with complete stripping between rounds when using antibodies from the same species. Drawing from advanced antibody design principles, evaluate potentially cross-reactive epitopes computationally before experimental implementation . The table below outlines critical parameters for successful multiplexing:
| Multiplexing Factor | Technical Consideration | Implementation Strategy |
|---|---|---|
| Antibody species compatibility | Secondary antibody cross-reactivity | Use antibodies from different species |
| Signal separation | Fluorophore spectral overlap | Implement sequential scanning with distinct emission filters |
| Epitope accessibility | Steric hindrance between antibodies | Target spatially separated epitopes |
| Protocol compatibility | Buffer incompatibilities | Validate each antibody independently before multiplexing |
| Quantitative accuracy | Signal bleeding/interference | Include single-stained controls for signal normalization |
This strategic approach enables reliable simultaneous detection of multiple proteins alongside At2g20380.
Machine learning significantly enhances At2g20380 antibody development through several mechanisms. Recent advances combining high-throughput sequencing with machine learning enable predictions beyond experimentally observed sequences . Implement biophysically interpretable models to disentangle different binding modes, even when dealing with chemically similar epitopes. These models associate each potential epitope with a distinct binding mode, enabling prediction and generation of specific variants beyond those observed experimentally . Neural network approaches can identify critical sequence patterns correlated with binding specificity, informing directed mutagenesis strategies. This computational framework can optimize over energy functions associated with each binding mode to either minimize cross-reactivity or enhance multi-target recognition. When combined with high-performance computing, these approaches can evaluate millions of potential variants, dramatically accelerating antibody engineering compared to traditional display methods . This integration of computation and experimentation represents the cutting edge of antibody research methodology.